The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer

Overview of attention for article published in Frontiers in oncology, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,326 followers.

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer https://t.co/CQ52WnzB8H

12 Nov 2021

Reply Repost Favourite

New research: The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer: Background Circulating tumor DNA (ctDNA) levels and blood tumor mutation burden (bTMB) have a significant impact on the prognosis of tumor… https://t.co/l

01 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.